Active substanceDioxomethyltetrahydropyrimidine + RetinolDioxomethyltetrahydropyrimidine + Retinol Similar drugsTo uncover Redecyl® ointment externally RETYNOIDS FNPP, CJSC Russia Dosage form: & nbspOintment for external use. Composition:Active substances: retinol palmitate (vitamin A) (in terms of 100% retinol palmitate) - 0.5 g (composition per 1.0 g of substance: retinol palmitate - 1.7 million ME, butylhydroxyansul - 9 mg, butylhydroxytoluene - 9 mg or retinol palmitate - 1.7 million ME, butylhydroxytoluene-17 mg, sunflower oil up to 1.0 g or retinol palmitate - 1.7 million ME, butyl hydroxy anisole - 5.5 mg, butylhydroxytoluene - 5.5 mg), dioxomethyltetrahydropyrimidine (methyluracil) 3.0 g.Excipients: alpha-tocopherol (vitamin E) 0.2 g, emulsion wax 8.0 g, vaseline oil 8.0 g, glycerol (glycerin) 10.0 g, ethanol (ethyl alcohol) 95% 10.0 g, purified water up to 100.0 g. Description:Homogeneous ointment from white to light yellow color. Pharmacotherapeutic group:Dermatoprotective agent. ATX: & nbspD.11.A.X Other preparations for the treatment of skin diseases Pharmacodynamics:It stimulates skin regeneration, enhances the reproduction of skin epithelial cells, inhibits keratinization, hinders the development of hyperkeratosis. Local action is due to the presence on the cell surface of the epithelium of specific retinol-binding receptors. Pharmacokinetics:Redecyl® easily penetrates the skin, the maximum concentration of active substances in the blood is reached 3-4 hours after application and is maintained for 12 hours. The half-life is 5.5 hours. Indications:Ichthyosis, hyperkeratosis, seborrheic dermatitis, psoriasis, pyoderma, atopic dermatitis, neurodermatitis, eczema, frostbite, burns, erosion, ulcers, cracks, with skin atrophy after prolonged use of glucocorticosteroid preparations. Contraindications:Hypersensitivity to the components of the drug, hypervitaminosis A, acute inflammatory skin diseases. Pregnancy and lactation:It is not recommended to apply to large areas of the skin during pregnancy (I trimester), breast-feeding. Dosing and Administration:Ointment is applied a thin layer on the affected skin in the morning and evening for 4-12 weeks. Side effects:Ointment is well tolerated. In some cases, itching and reddening of the skin can occur in the areas where the drug is applied, which requires a temporary discontinuation of the drug before the process is reduced. Allergic reactions are possible. Overdose:Not found. Interaction:Do not use in combination with other drugs containing vitamin A and retinoids to avoid hypervitaminosis A. Incompatible with tetracycline antibiotics. Form release / dosage:Ointment for external use in tubes of 10, 20 and 35 g. Packaging:Tubu together with instructions for use are placed in a pack of cardboard. Storage conditions:At a temperature of 2 to 8 0C. Do not allow freezing.Keep out of the reach of children. Shelf life:2 years. The drug should not be used after the expiration date. Terms of leave from pharmacies:Without recipe Registration number:P N001031 / 01 Date of registration:07.08.2007 The owner of the registration certificate:RETYNOIDS FNPP, CJSC RETYNOIDS FNPP, CJSC Russia Manufacturer: & nbspRETYNOIDS FNPP, CJSC Russia Information update date: & nbsp06.08.2015 Illustrated instructions × Illustrated instructions Instructions